Press Releases
6/25/08:
FDA Grants Priority Review for MediQuest’s Drug Application to treat Raynaud’s Disease
4/28/08:
MediQuest Therapeutics Submits Drug Application to FDA to treat Raynaud's Disease
1/7/08:
MediQuest Hires Pharmaceutical Industry Veteran as Executive VP and Chief Clinical Officer
7/2/07:
MediQuest Hires Pharmaceutical Industry Veteran as Senior VP of Sales
6/25/07:
MediQuest Concludes Confirmatory Phase III Study of Raynaud's Therapy
5/17/07:
MQX-503 Findings to be Presented at International Scleroderma Conference
5/3/07:
MediQuest Therapeutics to Present Company Overview at BIO 2007 Business Forum
3/19/07:
MediQuest Therapeutics Invited to Present at Invest Northwest Conference
2/7/07:
MediQuest Hires Pharmaceutical Industry Veteran as VP, Clinical Development
11/29/06:
MediQuest hires former CFO for Roche Consumer Health as new Chief Financial Officer
11/13/06:
MQX-503 Phase IIIa clinical trial results hold promise for millions suffering from Raynaud's Disease
10/16/06:
MediQuest Therapeutics, Inc. Announces Addition to Management Team
7/13/06:
Dr. Jeff Gregory Joins MediQuest Therapeutics, Inc.'s Management Team
6/15/06:
MediQuest Therapeutics Raises $16.0 Million In Series A Financing
1/10/06:
MediQuest Therapeutics Receives Special Protocol Assessment from the U.S. FDA
1/4/06:
MediQuest Therapeutics, Inc. Enrolls Patients in its Phase IIB Clinical Study for the Treatment of Onychomycosis (Toenail Fungus)
12/8/05:
MediQuest Therapeutics, Inc. Completes Phase IIIA Clinical Trials for Raynaud's Phenomenon
11/14/05:
Patent Issued to MediQuest Therapeutics, Inc. for its Compounds Targeting Inflammation and Undesirable Cell Proliferation
2/21/05:
MediQuest Panel Test Demonstrates Underarm Hair Growth Control
2/9/04:
MediQuest Therapeutics Purchases Assets of IntegriDerm
7/14/03:
MediQuest Therapeutics Purchases Assets of Taktix
6/2/03:
MediQuest Therapeutics Receives NIH Funding
2/5/03:
Tyler Ellison Joins MediQuest Therapeutics
Press Coverage
Seattle Times 4/28/08:
Mediquest asks for FDA approval of drug
Fierce Biotech 11/8/2007:
Emerging Drug Developer: MediQuest Therapeutics
Seattle PI 8/18/2007:
MediQuest on the cusp of marketing first product
Daily Herald 6/16/2006:
Bothell firm in the money
Daily Herald 1/30/2006:
Calling their own shots
Contact Us
|
